Why the study?
Does CO2 pneumoperitoneum cause metabolic changes (PaCO2, EtCO2, pH, bicarbonate) in patients undergoing laparoscopic cholecystectomy?
Does CO2 pneumoperitoneum cause metabolic changes (PaCO2, EtCO2, pH, bicarbonate) in patients undergoing laparoscopic cholecystectomy?
This observational study aims to evaluate the metabolic effects of CO2 pneumoperitoneum and the role of lung protective ventilation during laparoscopic cholecystectomy.
Should not change ventilation practice; this Level 3 cohort study leaves metabolic effects of CO2 pneumoperitoneum hypothesis-generating for RCTs.
Laparoscopically performed surgeries have increased manifold as they have provided many advantages when compared to traditional way of performing surgeries. But laparoscopic technique has its own disadvantages, which may be in form of metabolic effects of CO2 pneumoperitoneum. Current observation study was designed for observing metabolic changes in form of PaCO2, EtCO2, pH and bicarbonate levels in patients undergoing laparoscopic cholecystectomy and their effects on patient if any. Role of lung protective ventilation in managing PaCO2 and to ascertain the need of arterial blood gas monitoring in presence of EtCO2 monitoring in laparoscopic procedures like cholecystectomy.
No takes yet. Share an insight, caveat, or question.
Hakeem et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: